Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
WasabiCard completes nearly $10 million Pre-A round of financing, with participation from renowned institutions such as Vernal Capital and Avenir Group

WasabiCard completes nearly $10 million Pre-A round of financing, with participation from renowned institutions such as Vernal Capital and Avenir Group

ChaincatcherChaincatcher2026/06/03 02:02
Show original

ChainCatcher news, the global stablecoin payment infrastructure platform WasabiCard announced today that it has completed a Pre-A round of financing. Including previous rounds, the company's total financing has now reached nearly 10 million US dollars, with investments from four well-known institutions: Vernal Capital, Avenir Group, Vision Plus Capital, and 01VC.

This round of financing will be used to build and improve global payment infrastructure, compliance systems, and business layouts in key markets, enhancing cross-border payment service capabilities and global operational capacity, and further promoting the company's construction of a compliant, efficient, next-generation financial infrastructure for the internet era.

As stablecoins gradually move from trading scenarios to real-world business applications, the demand from enterprises for global payment, international card issuing, fund management, and cross-border settlement infrastructure continues to grow. WasabiCard currently serves over 500 enterprise clients worldwide, with the cumulative number of cards issued exceeding 500,000, and the platform's total transaction volume surpassing 1 billion US dollars.

In the future, WasabiCard will continue to expand its global payment network and multi-chain payment ecosystem, promoting the further adoption of stablecoin payments in global commercial scenarios.

News Image 0
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Third Life World signs deal to buy voting control of Transglobal Management Group

Third Life World signed a definitive control share purchase agreement to take voting control of Transglobal Management Group (TMGI). The deal transfers a Series A Preferred control block holding a majority of voting rights to Third Life World. TMGI plans to make Third Life World’s AI-agent virtual world platform its core operating business. TMGI will create new Series B Preferred Stock to support the purchase; closing remains subject to customary conditions. At closing, controlling shareholder Marc Angell will resign his officer roles and stay on as a consultant during the transition. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transglobal Management Group Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610081100PRIMZONEFULLFEED9842281) on October 08, 2026, and is solely responsible for the information contained therein.

Bitget•2026/10/08 15:00

BUZZ-CSL plans to convert all its plasma centers in the US to use Haemonetics equipment, driving the company's stock price to soar

October 8 – ** Shares of medical device manufacturer Haemonetics (HAE.N) surged nearly 16% to $117.81 ** The stock hit an intraday high of $120.61, marking its highest level since early 2021 ** The company stated that CSL Plasma, a subsidiary of Australia’s CSL Group (CSL.AX), expects to transition all its U.S. plasma collection centers to using HAE’s NexSys devices and kits by the end of 2027 ** CSL has also terminated its agreement with HAE rival Terumo (Terumo 4543.T) – according to BTIG ** This transition will help HAE win back business lost since 2021, when its largest plasma client CSL announced it would not renew its U.S. supply contract ** BTIG estimates that, based on approximately $155 million in revenue HAE generated from CSL’s U.S. business in fiscal year 2024, this account could add about $0.60 per share to adjusted earnings annually, though it notes that actual revenue and profit margins remain unclear ** The brokerage maintained its “Buy” rating and raised its price target from $110 to $130, stating that the deal alleviates market share loss concerns and boosts sales growth prospects ** Including today’s gains, the stock is up 49.46% so far this year (For the convenience of non-English speakers, Reuters provides its reports in several other languages through automated translation. Because automated translation may be inaccurate or lack needed context, Reuters does not guarantee the accuracy of the automated text, which is offered purely as a reader service. Reuters accepts no liability for any damage or loss caused by the use of automated translation services.)

路透社•2026/10/08 14:36